Projects funded by the NCN
Uracil in DNA and aberrant DNA methylation/hydroxymethylation as a new biomarkers of multiple myeloma development? A search for a possible link between genetic/epigenetic DNA modifications and multiple myeloma evolution.
2020/39/B/NZ5/01099
Keywords:
epigenetics active DNA demethylation uracil multiple myeloma
Descriptors:
- NZ5_5: Diagnostics in human diseases
- NZ5_7: Human disease treatment
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Uniwersytet Mikołaja Kopernika w Toruniu, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy, Wydział Farmaceutyczny
woj. kujawsko-pomorskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 14
Call: OPUS 20 - announced on 2020-09-15
Amount awarded: 2 304 960 PLN
Project start date (Y-m-d): 2021-10-08
Project end date (Y-m-d): 2025-10-07
Project duration:: 48 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.